Human and bovine lactoferrins in the milk of recombinant human lactoferrin-transgenic dairy cows during lactation

Biotechnology Journal

Volumn 1, Issue 4, 2006, Pages 410-412

  Hyvönen, Paula ^a   Suojala, Leena ^b   Haaranen, Johanna ^a   von Wright, Atte ^a   Pyörälä, Satu ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Lactation; Lactoferrin; Transgenic cows

Indexed keywords

DAIRY COW; DEFENCE MECHANISMS; HUMAN LACTOFERRIN; LACTATION; LACTOFERRIN; MAMMARY GLAND; MEAN CONCENTRATIONS; MILK YIELD; SOMATIC CELL COUNT; TRANSGENICS;

BODY FLUIDS; MAMMALS; PHYSIOLOGY;

DAIRIES;

LACTOFERRIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CATTLE; CHEMISTRY; GENETIC ENHANCEMENT; GENETICS; HUMAN; LACTATION; METABOLISM; METHODOLOGY; MILK; PROTEIN ENGINEERING; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CATTLE; GENETIC ENHANCEMENT; HUMANS; LACTATION; LACTOFERRIN; MILK; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 33750486467     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200600016     Document Type: Article

References (25)

1. Ward, P.P., Uribe-Luna, S., Conneely, O.M., Lactoferrin and host defense. Biochem. Cell Biol. 2002, 80, 95-102.
2. Brock, J.H, The physiology of lactoferrin. Biochem. Cell Biol. 2002, 80, 1-6.
3. Legrand, D., Elsass, E., Pierce, A., Mazurier, J., Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. BioMetals 2004, 17, 225-229.
4. Nuijens, J.H., Geerts, M., Strijker, R., Pieper, F., de Boer, H.A., A strategy to increase resistance in dairy cows: expression of human lactoferrin in the milk of transgenic cows. IDF Mastitis News 1993, 134, 16-18.
5. Harmon, R.J., Schanbacher, F.L., Ferguson, L.C., Smith, K.L., Concentration of lactoferrin in milk of normal lactating cows and changes occuring during mastitis. Am. J. Vet. Res. 1975, 36, 1001-1007.
6. Smith, K.L., Schanbacher, F.L., Lactoferrin as a factor of resistance to infection of the bovine mammary gland. J. Am. Vet. Med. Assoc. 1977, 170, 1224-1227.
7. Welty, F.K., Smith, K.L., Schanbacher, F.L., Lactoferrin concentration during involution of the bovine mammary gland. J. Dairy Sci. 1975, 59, 224-231.
8. S nchez, L., Aranda, P., Pérez, M.D., Calvo, M., Concentration of lactoferrin and transferrin throughout lactation in cow's colostrum and milk. Biol. Chem. Hoppe-Seyler 1988, 369, 1005-1008.
9. Sordillo, L.M., Streicher, K.L., Mammary gland immunity and mastitis susceptibility. J. Mamm. Gland Biol. Neopl. 2002, 7, 135-146.
10. Kawai, K, Hagiwara, S., Anri, A., Nagahata, H., Lactoferrin concentration in milk of bovine clinical mastitis. Vet. Res. Commun. 1999, 23, 391-398.
11. Hagiwara, S., Kawai, K., Anri, A., Nagahata, H., Lactoferrin concentrations in milk from normal and subclinical mastitic Cows. J. Vet. Sci. 2003, 65, 319-323.
12. Krimpenfort, P., Rademakers, A., Eyestone, W., van der Schans, A., van de Broek, S. et al., Generation of transgenic dairy cattle using 'in vitro' embryo production. Biotechnology (NY) 1991, 9, 844-847.
13. Brink, M.F., Bishop, M.D., Pieper, F.R., Developing efficient strategies for the generation of transgenic cattle which produce biopharmaceuticals in milk. Theriogenology 2000, 53, 139-148.
14. van Berkel, P.H.C., Welling, M.M., Geerts, M., van Veen, H.A., Ravensbergen, B. et al., Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat. Biotechnol. 2002, 20, 484-487.
15. Thomassen E.A., van Veen, H.A., van Berkel, P.H., Nuijens, J.H., Abrahams J.P., The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human-derived lactoferrin. Transgenic Res. 2005, 14: 397-405.
16. van Berkel, P.H.C., van Veen, H.A., Geerts, M.E.J., de Boer, H.A., Nuijens, J.H., Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants. Biochem. J. 1996, 319, 117-122.
17. Bramley, A.J., Foster, R., Effects of lysotaphin on Staphylococcus aureus infections of the mouse mammary gland. Res. Vet. Sci. 1990, 49, 120-121.
18. Maga, E.A., Genetigally engineered livestock: Closer than we think? Trends Biotechnol. 2005, 23, 533-535.
19. Rainard, P., Tackling mastitis in dairy cows. Nat. Biotechnol. 2005, 23, 430-432.
20. Wall, R.L., Powell, A.M., Paape, M.J., Kerr, D.E., Bannerman, D.D. et al., Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat. Biotechnol. 2005, 23, 445-451.
21. Kutila, T., Pyörälä, S., Saloniemi, H., Kaartinen, L., Antibacterial effect of bovine lactoferrin against udder pathogens. Acta Vet. Scand. 2003, 44, 35-42.
22. Komine, K., Komine, Y., Kuroishi, T., Kobayashi, J., Obara, Y. et al., Small molecule lactoferrin with an inflammatory effect but no apparent antibacterial activity in mastitic mammary gland secretion. J. Vet. Med. Sci. 2005, 67, 667-677.
23. Joslin, R.S., Erickson, P.S., Santoro, H.M., Whitehouse, N.L., Schwab, C.G. et al., Lactoferrin supplementation to dairy calves. J. Dairy Sci. 2002, 85, 1237-1242.
24. Robblee, E.D., Erickson, P.S., Whitehouse, N.L., McLaughlin, A.M., Schwab, C.G. et al., Supplemental lactoferrin improves health and growth of Holstein calves during the preweaning phase. J. Dairy Sci. 2003, 86, 1458-1464.
25. Schottstedt, T., Murri, C., Morel, C., Philipone, C., Hammon, H.M. et al., Effects on feeding vitamin A and lactoferrin on epithelium of lymphoid tissues of intestine of neonatal calves. J. Dairy Sci. 2005, 88, 1050-1061.